On November 4, customs officers in Hong Kong examined two parcels that had arrived from the UK via Shenzhen Bay Port. After inspection, six syringes suspected to be pharmaceutical products were found inside these two parcels. The estimated value of the goods was approximately HKD 16,000. Following further investigation, two people who are suspected to be the recipients of the parcels were arrested on November 5, one being a 40-year-old man and the other a 41-year-old woman. The case is still under investigation and the two suspects have been released on bail. According to the Import and Export Ordinance, any individual who imports pharmaceutical products and medicines without a valid import license is in violation of the law and can be fined up to HKD 500,000 and imprisoned for up to two years upon conviction. Citizens are encouraged to report suspicious smuggling activities by calling the customs 24-hour hotline at 182 8080 or through the dedicated email account ([email protected]), or by using the online form available at (eform.cefs.gov.hk/form/ced002).

The detected syringes were found inside two packages that passengers had brought into Hong Kong through Shenzhen Bay Port from the UK. The investigation into this incident is ongoing, and the customs authorities are keen on receiving public cooperation and information to combat such illegal activities. The public can easily get in touch with the customs department through multiple avenues, including the hotline and email, to report such smuggling activities.

This case highlights the ongoing challenge faced by customs authorities in preventing illegal importations of pharmaceutical products. With the rise of international package deliveries, customs officers are vigilant in their efforts to curb the flow of banned or unregulated goods into the territory. The stringent regulations and swift response mechanisms in place serve as a deterrent for potential smugglers and underscore the commitment of Hong Kong's customs department to upholding the law and ensuring public safety.